Research in Mozambique has found that the introduction of rapid point-of-care CD4 testing* almost halved the number of patients who dropped out before starting antiretroviral therapy (ART), and nearly ...

Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...

CD4+ T cells, or helper T cells, are one type of lymphocyte that helps coordinate the immune response against infection and disease. They interact and activate other cells in the immune system. The ...

Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...

Introduction Postpartum disengagement from HIV care increases risks for adverse maternal health outcomes and transmission of ...

Human immunodeficiency virus (HIV) attacks CD4 cells, which are a small part of the white blood cells. In acute HIV, white blood cell count may drop slightly but still look “normal.” A white blood ...